Ryu JH - Search Results

1

RNAi-Based Approaches for Pancreatic Cancer Therapy.

Kim MJ, Chang H, Nam G, Ko Y, Kim SH, Roberts TM, Ryu JH. Kim MJ, et al. Among authors: ryu jh. Pharmaceutics. 2021 Oct 8;13(10):1638. doi: 10.3390/pharmaceutics13101638. Pharmaceutics. 2021. PMID: 34683931 Free PMC article. Review.

2

In vivo fluorescence imaging for cancer diagnosis using receptor-targeted epidermal growth factor-based nanoprobe.

Ryu JH, Shin M, Kim SA, Lee S, Kim H, Koo H, Kim BS, Song HK, Kim SH, Choi K, Kwon IC, Jeon H, Kim K. Ryu JH, et al. Biomaterials. 2013 Dec;34(36):9149-59. doi: 10.1016/j.biomaterials.2013.08.026. Epub 2013 Aug 30. Biomaterials. 2013. PMID: 23998858

3

Theranostic nanoparticles for future personalized medicine.

Ryu JH, Lee S, Son S, Kim SH, Leary JF, Choi K, Kwon IC. Ryu JH, et al. J Control Release. 2014 Sep 28;190:477-84. doi: 10.1016/j.jconrel.2014.04.027. Epub 2014 Apr 26. J Control Release. 2014. PMID: 24780269 Review.

4

Cathepsin B Imaging to Predict Quality of Engineered Cartilage.

Yhee JY, Kim YJ, Ryu JH, Yoon HY, Chang H, Park JH, Lee H, Jang HS, Jeong U, Kim K, Kang SW. Yhee JY, et al. Among authors: ryu jh. Macromol Biosci. 2015 Sep;15(9):1224-32. doi: 10.1002/mabi.201500215. Epub 2015 Jul 14. Macromol Biosci. 2015. PMID: 26175259

5

Bioorthogonal Copper Free Click Chemistry for Labeling and Tracking of Chondrocytes In Vivo.

Yoon HI, Yhee JY, Na JH, Lee S, Lee H, Kang SW, Chang H, Ryu JH, Lee S, Kwon IC, Cho YW, Kim K. Yoon HI, et al. Among authors: ryu jh. Bioconjug Chem. 2016 Apr 20;27(4):927-36. doi: 10.1021/acs.bioconjchem.6b00010. Epub 2016 Mar 10. Bioconjug Chem. 2016. PMID: 26930274

6

Predicting the in vivo accumulation of nanoparticles in tumor based on in vitro macrophage uptake and circulation in zebrafish.

Chang H, Yhee JY, Jang GH, You DG, Ryu JH, Choi Y, Na JH, Park JH, Lee KH, Choi K, Kim K, Kwon IC. Chang H, et al. Among authors: ryu jh. J Control Release. 2016 Dec 28;244(Pt B):205-213. doi: 10.1016/j.jconrel.2016.07.025. Epub 2016 Jul 17. J Control Release. 2016. PMID: 27435681

7

Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment.

Park J, Choi Y, Chang H, Um W, Ryu JH, Kwon IC. Park J, et al. Among authors: ryu jh. Theranostics. 2019 Oct 17;9(26):8073-8090. doi: 10.7150/thno.37198. eCollection 2019. Theranostics. 2019. PMID: 31754382 Free PMC article. Review.

8

Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer treatment.

Kim MJ, Lee SJ, Ryu JH, Kim SH, Kwon IC, Roberts TM. Kim MJ, et al. Among authors: ryu jh. J Control Release. 2020 Feb;318:98-108. doi: 10.1016/j.jconrel.2019.12.019. Epub 2019 Dec 12. J Control Release. 2020. PMID: 31838203 Free PMC article.

9

Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity.

Yang S, Shim MK, Kim WJ, Choi J, Nam GH, Kim J, Kim J, Moon Y, Kim HY, Park J, Park Y, Kim IS, Ryu JH, Kim K. Yang S, et al. Among authors: ryu jh. Biomaterials. 2021 May;272:120791. doi: 10.1016/j.biomaterials.2021.120791. Epub 2021 Apr 1. Biomaterials. 2021. PMID: 33831739

10

Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy.

Ryu JH, Koo H, Sun IC, Yuk SH, Choi K, Kim K, Kwon IC. Ryu JH, et al. Adv Drug Deliv Rev. 2012 Oct;64(13):1447-58. doi: 10.1016/j.addr.2012.06.012. Epub 2012 Jul 4. Adv Drug Deliv Rev. 2012. PMID: 22772034 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,013 results

Search Page